amifampridine phosphate
amifampridine phosphate is listed in the FDA National Drug Code directory with 3 NDC codes, marketed under brand name including Firdapse. Available dosage forms: powder, tablet.
Drug Details
- Generic Name
- amifampridine phosphate
- Brand Names
- Firdapse
- Application Number
- NDA208078
- Sponsor
- Catalent Micron Technologies, Inc.
- NDC Codes
- 3
- Dosage Forms
- POWDER, TABLET
- Routes
- ORAL
- Active Ingredients
- AMIFAMPRIDINE PHOSPHATE
Indications and Usage
1 INDICATIONS AND USAGE FIRDAPSE ® is indicated for the treatment of Lambert-Eaton myasthenic syndrome (LEMS) in adults and pediatric patients 6 years of age and older. FIRDAPSE is a potassium channel blocker indicated for the treatment of Lambert-Eaton myasthenic syndrome (LEMS) in adults and pediatric patients 6 years of age and older. ( 1 )